Piper Jaffray Companies Reaffirms “Overweight” Rating for Tabula Rasa HealthCare (TRHC)

Piper Jaffray Companies restated their overweight rating on shares of Tabula Rasa HealthCare (NASDAQ:TRHC) in a research report released on Thursday, The Fly reports. They currently have a $80.00 target price on the stock.

A number of other equities analysts have also commented on TRHC. Zacks Investment Research lowered shares of Tabula Rasa HealthCare from a hold rating to a sell rating in a report on Saturday, November 10th. BidaskClub upgraded shares of Tabula Rasa HealthCare from a hold rating to a buy rating in a research note on Wednesday, November 28th. Chardan Capital upped their target price on shares of Tabula Rasa HealthCare from $77.00 to $91.00 and gave the company a buy rating in a research note on Wednesday, November 7th. Cantor Fitzgerald restated a buy rating and issued a $99.00 target price on shares of Tabula Rasa HealthCare in a research note on Tuesday, November 6th. Finally, Citigroup upped their target price on shares of Tabula Rasa HealthCare from $57.00 to $76.00 and gave the company a buy rating in a research note on Thursday, August 9th. Two research analysts have rated the stock with a hold rating and eleven have issued a buy rating to the company. The stock has a consensus rating of Buy and an average target price of $82.50.

TRHC stock traded down $2.15 during trading on Thursday, reaching $71.34. The stock had a trading volume of 10,511 shares, compared to its average volume of 246,704. Tabula Rasa HealthCare has a 1-year low of $27.31 and a 1-year high of $91.16. The company has a debt-to-equity ratio of 0.28, a current ratio of 0.49 and a quick ratio of 0.46. The firm has a market capitalization of $1.48 billion, a P/E ratio of -1,782.13, a P/E/G ratio of 6.89 and a beta of 2.53.

Tabula Rasa HealthCare (NASDAQ:TRHC) last issued its quarterly earnings data on Tuesday, November 6th. The company reported $0.26 EPS for the quarter, topping analysts’ consensus estimates of $0.19 by $0.07. Tabula Rasa HealthCare had a negative net margin of 13.49% and a positive return on equity of 7.63%. The firm had revenue of $54.42 million for the quarter, compared to analyst estimates of $52.87 million. During the same quarter in the previous year, the business posted $0.08 EPS. The firm’s revenue was up 66.3% compared to the same quarter last year. On average, sell-side analysts anticipate that Tabula Rasa HealthCare will post 0.42 EPS for the current year.

In related news, President Orsula V. Knowlton bought 7,500 shares of the business’s stock in a transaction dated Monday, November 12th. The shares were acquired at an average price of $65.00 per share, for a total transaction of $487,500.00. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, President Orsula V. Knowlton sold 8,000 shares of the company’s stock in a transaction dated Monday, September 17th. The shares were sold at an average price of $79.80, for a total transaction of $638,400.00. The disclosure for this sale can be found here. In the last 90 days, insiders sold 50,000 shares of company stock worth $3,655,920. Company insiders own 14.00% of the company’s stock.

Institutional investors have recently modified their holdings of the company. Mount Yale Investment Advisors LLC bought a new stake in shares of Tabula Rasa HealthCare during the 2nd quarter valued at about $111,000. Meadow Creek Investment Management LLC bought a new stake in shares of Tabula Rasa HealthCare during the 2nd quarter valued at about $115,000. Envestnet Asset Management Inc. bought a new stake in shares of Tabula Rasa HealthCare during the 2nd quarter valued at about $130,000. Pinebridge Investments L.P. bought a new stake in shares of Tabula Rasa HealthCare during the 2nd quarter valued at about $181,000. Finally, Piedmont Investment Advisors LLC bought a new stake in shares of Tabula Rasa HealthCare during the 2nd quarter valued at about $206,000. Institutional investors and hedge funds own 74.88% of the company’s stock.

Tabula Rasa HealthCare Company Profile

Tabula Rasa HealthCare, Inc operates as a healthcare technology company in the United States. It offers medication risk management, pharmacy cost management, and medicare risk adjustment services. The company offers its technology-enabled products and services to prescribers, pharmacists, and healthcare organizations for medication risk management and risk adjustment.

Featured Story: Coverage Ratio

The Fly

Analyst Recommendations for Tabula Rasa HealthCare (NASDAQ:TRHC)

Receive News & Ratings for Tabula Rasa HealthCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tabula Rasa HealthCare and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply